Abstract
The COVID-19 pandemic focused attention on workplace mental health (MH) supports for healthcare workers (HCWs).
Methods HCWs in a Canadian cohort reported availability and use of workplace MH supports in October 2020, April 2021 and 2022. At recruitment (April-October 2020) they reported pre-pandemic MH. They completed the Hospital Anxiety and Depression Scale (HADS) at each contact. Availability and use of supports were examined by pandemic phase, workplace, work role and, for use, gender, age, pre-pandemic and current MH. Impact was assessed as MH in 2021/2022 following use in 2020.
Results Reports of availability, use and HADS scores were obtained from 4400 HCWs working with patients. Access to MH supports increased during the pandemic, with 94% reporting access to some workplace support by 2022. Half the HCWs had at least one clinically significant HADS score during the pandemic. The proportion with high anxiety scores decreased from 29% to 24% as the pandemic progressed: proportions with high depression scores remained close to 10%. Those with a history of pre-pandemic or current mental ill-health formed the majority of HCWs using MH supports. 25% of those with high HADS scores did not use supports, with depressed males least likely to report use. HCWs using an Employment Assistance Program at the 2nd contact had lower HADS scores at next follow-up but this was not sustained.
Conclusion HCWs reported increasing availability and use of MH supports as the pandemic progressed but one in four of those with anxiety and, particularly, depression did not seek support.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Seed funding was obtained from the College of Physicians and Surgeons of Alberta. Grant funding was obtained from the Canadian Institutes of Health Research (Funding Reference number 173209). This funding was extended by a grant from the Canadian Immunology Task Force
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Approval for each element of the study was given by the University of Alberta Heath Ethics Board (Pr000099700). The study was also reviewed and approved by Unity Health Toronto Research Ethics Board (REB# 20-298) for those elements coordinated locally for the Ontario participants.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The data underlying this article will be shared on reasonable request to the corresponding author.
